» Articles » PMID: 32775633

A Polymer-based Systemic Hemostatic Agent

Overview
Journal Sci Adv
Specialties Biology
Science
Date 2020 Aug 11
PMID 32775633
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Uncontrolled noncompressible hemorrhage is a major cause of mortality following traumatic injuries in civilian and military populations. An injectable hemostat for point-of-care treatment of noncompressible hemorrhage represents an urgent medical need. Here, we describe an injectable hemostatic agent via polymer peptide interfusion (HAPPI), a hyaluronic acid conjugate with a collagen-binding peptide and a von Willebrand factor-binding peptide. HAPPI exhibited selective binding to activated platelets and promoted their accumulation at the wound site in vitro. In vivo studies in mouse tail vein laceration model demonstrated a reduction of >97% in both bleeding time and blood loss. A 284% improvement in the survival time was observed in the rat inferior vena cava traumatic model. Lyophilized HAPPI could be stably stored at room temperature for several months and reconstituted during therapeutic intervention. HAPPI provides a potentially clinically translatable intravenous hemostat.

Citing Articles

Water absorption dynamics in medical foam: empirical validation of the Lucas-Washburn model.

Mu W, Sun H, Cao L Eur Phys J E Soft Matter. 2025; 48(3):13.

PMID: 40042719 PMC: 11882628. DOI: 10.1140/epje/s10189-025-00478-3.


Injectable platelet-mimicking silk protein-peptide conjugate microspheres for hemostasis modulation and targeted treatment of internal bleeding.

Shuai Y, Qian Y, Zheng M, Yan C, Wang J, Wang P J Nanobiotechnology. 2025; 23(1):128.

PMID: 39979914 PMC: 11844073. DOI: 10.1186/s12951-025-03180-w.


A self-hygroscopic, rapidly self-gelling polysaccharide-based sponge with robust wet adhesion for non-compressible hemorrhage control and infected wounds healing.

Lei X, Liu M, Lu C, Han L, Jia J, Li Z Bioact Mater. 2025; 46():311-330.

PMID: 39811462 PMC: 11732608. DOI: 10.1016/j.bioactmat.2024.12.016.


An active shrinkage and antioxidative hydrogel with biomimetic mechanics functions modulates inflammation and fibrosis to promote skin regeneration.

Zhang T, Zhong X, Feng Z, Lin X, Chen C, Wang X Bioact Mater. 2024; 45:322-344.

PMID: 39669127 PMC: 11635612. DOI: 10.1016/j.bioactmat.2024.11.028.


Chitosan Hemostatic Dressings: Properties and Surgical Applications.

Cassano R, Perri P, Scarcello E, Piro P, Sole R, Curcio F Polymers (Basel). 2024; 16(13).

PMID: 39000626 PMC: 11244242. DOI: 10.3390/polym16131770.


References
1.
Hubbard W, Lashof-Sullivan M, Greenberg S, Norris C, Eck J, Lavik E . Hemostatic nanoparticles increase survival, mitigate neuropathology and alleviate anxiety in a rodent blast trauma model. Sci Rep. 2018; 8(1):10622. PMC: 6045585. DOI: 10.1038/s41598-018-28848-2. View

2.
Jiang L, Liu G, Liu H, Han J, Liu Z, Ma H . Molecular weight impact on the mechanical forces between hyaluronan and its receptor. Carbohydr Polym. 2018; 197:326-336. DOI: 10.1016/j.carbpol.2018.06.015. View

3.
Kruskall M . The perils of platelet transfusions. N Engl J Med. 1997; 337(26):1914-5. DOI: 10.1056/NEJM199712253372609. View

4.
Park C, Hartl C, Schmid D, Carmona E, Kim H, Goldberg M . Extended release of perioperative immunotherapy prevents tumor recurrence and eliminates metastases. Sci Transl Med. 2018; 10(433). DOI: 10.1126/scitranslmed.aar1916. View

5.
Chan L, Wang X, Wei H, Pozzo L, White N, Pun S . A synthetic fibrin cross-linking polymer for modulating clot properties and inducing hemostasis. Sci Transl Med. 2015; 7(277):277ra29. PMC: 4470483. DOI: 10.1126/scitranslmed.3010383. View